1. Davis PM, Nadler SG, Suchard SJ, etal 2005. Abatacept differentially modulates human B-cell and dendritic cell stimulated T-cell effector function. Ann Rheum Dis, 64(Suppl III):128.
2. Block and tackle: CTLA4Ig takes on lupus
3. Dougados M, Sherrer Y, Carrabba M, etal 2005. Abatacept provides significant and clinically meaningful efficacy in rheumatoid arthritis patients with inadequate responses to anti-TNF therapy: disease activity score 28 assessments in the ATTAIN trial. Ann Rheum Dis, 64(Suppl III):458.
4. Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy